Resistance trends in Haemophilus influenzae (PROTEKT years 1-3 [1999-2002])

Journal of Chemotherapy

Volumn 16, Issue SUPPL. 6, 2004, Pages 49-61

  Low, Donald E ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAMASE; CLARITHROMYCIN; KETOLIDE; TELITHROMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BLOOD CULTURE; CHILD; COMMUNICABLE DISEASE; DEMOGRAPHY; ENZYME SYNTHESIS; FEMALE; GENDER; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; HAEMOPHILUS INFLUENZAE; HOSPITAL PATIENT; HUMAN; INFANT; MALE; MIDDLE EAR; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; NONHUMAN; OUTPATIENT; PREVALENCE; RESPIRATORY TRACT INFECTION; REVIEW;

EID: 11144225878     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1080/1120009x.2004.11782402     Document Type: Review

References (11)

1. Borderon JC. Haemophilus influenzae: colonization and infection. Arch Pediatr 1995; 2: 249-254.
2. Murphy TF. Respiratory infections caused by non-typeable Haemophilus influenzae. Curr Opin Infect Dis 2003; 16: 129-134.
3. Jorgensen JH. Update on mechanisms and prevalence of antimicrobial resistance in Haemophilus influenzae. Clin Infect Dis 1992; 14: 1119-1123.
4. Doern GV, Brueggemann AB, Pierce G, Holley HP, Rauch A. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of β-lactamase-positive strains resistant to amoxicillin-clavulanate: Results of a national multicenter surveillance study. Antimicrob Agents Chemother 1997; 41: 292-297.
5. Felmingham D, Gruneberg RN and the Alexander Project Group. The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J Antimicrob Chemother 2000; 45: 191-203.
6. Sahm DF, Jones ME, Hickey ML, Diakun DR, Mani SV, Thornsberry C. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolates in Asia and Europe 1997-1998. J Antimicrob Chemother 2000; 45: 457-466.
7. Jacobs MR, Felmingham D, Appelbaum PC, Gruneberg RN and the Alexander Project Group. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 2003; 52: 229-246.
8. Thornsberry C, Sahm DF, Kelly LJ, et al. Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program. 1999-2000. Clin Infect Dis 2002; 34 (Suppl 1): S4-S16.
9. Karlowsky JA, Draghi DC, Thornsberry C, Jones ME, Critchley IA, Sahm DF. Antimicrobial susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in two successive respiratory seasons in the US. Int J Antimicrob Agents 2002; 20: 76-85.
10. Zhanel GG, Palatnick L, Nichol KA, Low DE, The CROSS Study Group, Hoban DJ. Antimicrobial Resistance in Haemophilus influenzae and Moraxella catarrhalis Respiratory Tract Isolates: Results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002. Antimicrob Agents Chemother 2003; 47: 1875-1881.
11. Karlowsky JA, Verma G, Zhanel GG, Hoban DJ. Presence of ROB-1 β-lactamase correlates with cefaclor resistance among recent isolates of Haemophilus influenzae. J Antimicrob Chemother 2000; 45: 871-875.